Search

everythinglearnresearchcommunity

for

Search:↓

Kidney cancer cells without folliculin are more sensitive to radiation due to increased self-eating cell death.

Stress may contribute to hair loss in alopecia areata by affecting immune responses and cell death in hair follicles.

Hair loss from Alopecia Areata is caused by both genes and environment, with several treatments available but challenges in cost and relapse remain.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Light affects skin health, aging, and cancer risk, and new light-based treatments and imaging are promising for skin care.

Psoriasis involves immune and genetic factors, and understanding these can improve treatments.

Hair follicles are key to treating vitiligo and alopecia areata, but challenges exist.

Systemic treatments like hydroxychloroquine and cyclosporine A help with Lichen Planopilaris and Frontal Fibrosing Alopecia, but ongoing treatment is needed.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Metformin, usually used for diabetes, can also help treat hair loss from alopecia areata due to its ability to reduce inflammation and stimulate new hair growth.

COVID-19 may harm male reproductive health and lower testosterone levels, potentially affecting fertility and causing erectile dysfunction. More research is needed.

Natural products might be safe, effective, and affordable treatments for hair loss.

Eicosanoids are crucial for skin health, and targeting their pathways may help treat skin conditions.

New understanding and treatments for hair loss are improving, but more research is needed.

Certain substances can protect against ear damage from some antibiotics in zebrafish.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

Key genes and pathways involved in thyroid eye disease were identified, aiding potential treatment and diagnosis.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Resistance exercise can reduce muscle protein issues caused by finasteride.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

The main prostate diseases in dogs are benign growth, infections, and cancer, with various treatments ranging from drugs to surgery, but cancer treatments have limited success.

Early hormones shape sex-specific differences in rat glands.

Personalized treatments for hair loss are becoming more effective by using genetic information.

The document concludes that the discussed biological mechanisms and potential therapies are not related to hair loss or hair growth.

Both vitiligo and alopecia areata involve an immune response triggered by stress and specific genes, with treatments targeting this pathway showing potential.

Valproic acid helps delay hair loss and increases survival time for high-grade glioma patients undergoing radiation therapy.

Finasteride may increase erectile dysfunction risk in patients with benign prostatic hyperplasia.

Antioxidants may help improve mitochondrial health and could be used to treat diseases related to cell damage.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

Dutasteride protects dopamine neurons in Parkinson's mice, but Finasteride doesn't.